Blog

BIOTECH FINANCES publishes a special issue citing Shahin Gharakhanian MD Consulting LLC

April 28, 2016

BIOTECH FINANCES, a leading professional publication for biotechnology executive and investors has published [online, and in paper, Lyon-Montreal] a special issue [no. 179, 11 April 2016], on the “francophone” biotech community in Boston MA has highlighted the role and cited Shahin Gharakhanian MD Consulting LLC.

Shahin Gharakhanian MD leads Program Committee for 3rd New England Life Sciences Panorama meeting at the Genzyme Center, Cambridge MA, USA ● Meeting Report

April 28, 2016

2016 NE Life Sciences Panorama Meeting 15 March SUMMARY

Shahin Gharakhanian MD leads Program Committee for 3rd New England Life Sciences Panorama meeting to be held 15 March 2016 at the Genzyme Center, Cambridge MA, USA

March 14, 2016

02.18.2016 FINAL PROGRAM Annual LS Panorama

Presentation at the International Conference on Vaccine R&D, Baltimore MD, 04 November, 2015

November 27, 2015

Methodological challenges in the Clinical Development of HIV Therapeutic Vaccines. Infection with Human Immunodeficiency Virus (HIV) is a chronic clinical state where discrete, viral replication and homeostatic proliferation of infected memory T cells maintain HIV reservoirs. The medical management of HIV is regarded as a major R&D achievement and...

Presentation of phase I and phase II clinical trial results at the IAS: International AIDS Society Conference & IAS HIV Cure Symposium

August 9, 2015

18-20 July 2015, Vancouver, Canada.

Dr Shahin Gharakhanian Interview

June 3, 2015

http://www.hiv-reservoir.net/

Shahin Gharakhanian MD, Leads the Program Committee of the 2015 Life Sciences Annual Panorama Meeting at the Genzyme Center, Cambridge MA, USA, 18 March 2015. Program Included.

March 16, 2015

FACCNE LIFE SCIENCES EVENT Cambridge 18MAR2015

We are pleased to announce a new collaboration agreement concluded between Shahin Gharakhanian MD Consulting LLC (Cambridge MA) and BIONOR PHARMA (Oslo, Norway).

November 10, 2014

BIONOR PHARMA is a leading vaccine company searching for breakthrough treatments for HIV and other lethal viruses [ www.bionorpharma.com ].

Presented at the 4th Conference on Vaccines & Vaccination, Valencia, Spain, 25 September 2015

September 23, 2014

VAC-3S vaccine, a novel approach to the therapeutic management of HIV Infection. Overview of phase I and phase II clinical vaccine development programs. R Ho Tsong Fang, O Launay, C Katlama, J Crouzet, B Autran, V Vieillard, P Debré, S Gharakhanian 2014.09 VAC-3S J Vaccines Vaccin 2014.55

Shahin Gharakhanian led the Program Committee and presented at the FACCNE Annual 2014 Life Sciences Event, 13 March 2014 @ the Genzyme Center, Cambridge MA.

April 6, 2014

The talk titled “New Initiatives in Academic Commercialization” highlights the University of Pennsylvania – UPenn – UPStart Program and the collaboration with NovoBioPharma a firm co-founded by Shahin Gharakhanian MD Consulting LLC. This is a new collaboration set up to provide innovative business and science solutions for academia-based early...